In the past 20 years we have seen the rise of a new era of cancer research that moved its focus away from the cancer cell itself and revealed a complexity of interactions, both within the tumor and with the host, that ultimately dictate the evolution and progression of the disease. We have witnessed the development of immunotherapies that changed the fate of many patients and new diagnostic strategies with the potential of changing clinical practice. In this article, several experts discuss what lies ahead.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccell.2022.02.019 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!